Inhalation performance of pollen-shape carrier in dry powder formulation: Effect of size and surface morphology

International Journal of Pharmaceutics

Volumn 413, Issue 1-2, 2011, Pages 93-102

  Hassan, Meer Saiful ^a   Lau, Raymond ^a  

^a NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

Author keywords

Drug mixing ratio; Dry powder inhalation; Emitted dose; Fine particle fraction; Particle size; Pollen shape carrier particles; Surface morphology

Indexed keywords

BUDESONIDE; DRUG CARRIER;

ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRY POWDER; FLOW RATE; PARTICLE SIZE; POWDER INHALER; PRIORITY JOURNAL; SURFACE PROPERTY;

ADMINISTRATION, INHALATION; AEROSOLS; BRONCHODILATOR AGENTS; BUDESONIDE; DRUG CARRIERS; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; DURAPATITE; EXCIPIENTS; MOLECULAR STRUCTURE; NEBULIZERS AND VAPORIZERS; PARTICLE SIZE; POLLEN; POWDERS; SURFACE PROPERTIES;

EID: 79957987387     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2011.04.033     Document Type: Article

References (40)

1. P. Begat, D.A.V. Morton, J.N. Staniforth, and R. Price The cohesive-adhesive balances in dry powder inhaler formulations. II. Influence on fine particle delivery characteristics Pharm. Res. 21 2004 1826 1833 (Pubitemid 39390095)
2. J. Broadhead, S. Rouan, I. Hau, and C. Rhodes The effect of process and formulation variables on the properties of spray-dried beta-galactosidase J. Pharm. Pharmacol. 46 1994 458 467 (Pubitemid 24179539)
3. M.B. Dolovich Measuring total and regional lung deposition using inhaled radiotracers J. Aerosol Med. 14 2001 35 44
4. M.-P. Flament, P. Leterme, and A. Gayot The influence of carrier roughness on adhesion, content uniformity and the in vitro deposition of terbutaline sulphate from dry powder inhalers Int. J. Pharm. 275 2004 201 209 (Pubitemid 38481532)
5. D.L. French, D.A. Edwards, and R.W. Niven The influence of formulation on emission, deaggregation and deposition of dry powders for inhalation J. Aerosol Sci. 27 1996 769 783 (Pubitemid 26234318)
6. I. Gonda Scintigraphic techniques for measuring in vivo deposition J. Aerosol Med. 9 1996 S 59 S 67
7. I. Gonda Targeting by deposition A.J. Hicky, Pharmaceutical Inhalation Aerosol Technology 2004 Marcel Dekker, Inc. New York
8. R. Guchardi, M. Frei, E. John, and J.S. Kaerger Influence of fine lactose and magnesium stearate on low dose dry powder inhaler formulations Int. J. Pharm. 348 2008 10 17 (Pubitemid 350266232)
9. M.S. Hassan, and R. Lau Feasibility study of pollen-shape drug carriers in dry powder inhalation J. Pharm. Sci. 99 2010 1309 1321
10. M.S. Hassan, and R. Lau Flow behavior and deposition study of pollen-shape carrier particles in an idealized inhalation path model Particuology 8 2010 51 59
11. M.S. Hassan, and R. Lau Inhalation performance of pollen-shape carrier in dry powder formulation with different drug mixing ratios: comparison with lactose carrier Int. J. Pharm. 386 2010 6 14
12. P.W.S. Heng, L.W. Chan, and L.T. Lim Quantification of the surface morphologies of lactose carriers and their effect on the in vitro deposition of salbutamol sulphate Chem. Pharm. Bull. 48 2000 393 398 (Pubitemid 30187256)
13. K. Iida, Y. Hayakawa, H. Okamoto, K. Danjo, and H. Leuenberger Evaluation of flow properties of dry powder inhalation of salbutamol sulfate with lactose carrier Chem. Pharm. Bull. 49 2001 1326
14. K. Iida, Y. Hayakawa, H. Okamoto, K. Danjo, and H. Luenberger Influence of storage humidity on the in vitro inhalation properties of salbutamol sulfate dry powder with surface covered lactose carrier Chem. Pharm. Bull. 52 2004 444 446 (Pubitemid 41694731)
15. N. Islam, P. Stewart, I. Larson, and P. Hartley Effect of carrier size on the dispersion of salmeterol xinafoate from interactive mixtures J. Pharm. Sci. 93 2004 1030 1038 (Pubitemid 38420412)
16. N.M. Kassem, and D. Ganderton The influence of carrier surface on the characteristics of inspirable powder aerosols J. Pharm. Pharmacol. 42 1990 11P
17. Y. Kawashima, T. Serigano, T. Hino, H. Yamamoto, and H. Takeuchi Effect of surface morphology of carrier lactose on dry powder inhalation property of pranlukast hydrate Int. J. Pharm. 172 1998 179 188 (Pubitemid 28430255)
18. H. Larhrib, M. Cespi, M.A. Dyas, M. Roberts, and J.L. Ford Engineered carrier with a long time of flight (TOF) to improve drug delivery from dry powder inhalation aerosols Drug Deliv. Lung (DDL) 2006 304 307
19. H. Larhrib, G.P. Martin, C. Marriott, and D. Prime The influence of carrier and drug morphology on drug delivery from dry powder formulations Int. J. Pharm. 257 2003 283 296 (Pubitemid 36507054)
20. H. Larhrib, G.P. Martin, D. Prime, and C. Marriott Characterisation and deposition studies of engineered lactose crystals with potential for use as a carrier for aerosolised salbutamol sulfate from dry powder inhalers Eur. J. Pharm. Sci. 19 2003 211 221 (Pubitemid 36918413)
21. H. Larhrib, X.M. Zeng, G.P. Martin, C. Marriott, and J. Pritchard The use of different grades of lactose as a carrier for aerosolised salbutamol sulphate Int. J. Pharm. 191 1999 1 14 (Pubitemid 29502173)
22. Q. Li, V. Rudolph, and W. Peukert London-van der Waals adhesiveness of rough particles Powder Technol. 161 2006 248 255 (Pubitemid 43120480)
23. Q. Li, V. Rudolph, B. Weigl, and A. Earl Interparticle van der Waals force in powder flowability and compactibility Int. J. Pharm. 280 2004 77 93 (Pubitemid 38950906)
24. M. Louey, M. Van Oort, and A. Hickey Aerosol dispersion of respirable particles in narrow size distributions produced by jet-milling and spray-drying techniques Pharm. Res. 21 2004 1200 1206 (Pubitemid 38954204)
25. M. Louey, M. Van Oort, and A. Hickey Aerosol dispersion of respirable particles in narrow size distributions using drug-alone and lactose-blend formulations Pharm. Res. 21 2004 1207 1213 (Pubitemid 38954205)
26. M.D. Louey, S. Razia, and P.J. Stewart Influence of physico-chemical carrier properties on the in vitro aerosol deposition from interactive mixtures Int. J. Pharm. 252 2003 87 98 (Pubitemid 36126617)
27. M. Mumenthaler, C.C. Hsu, and R. Pearlman Feasibility study on spray-drying protein pharmaceuticals: recombinant human growth hormone and tissue-type plasminogen activator Pharm. Res. 11 1994 12 20 (Pubitemid 24040758)
28. R.W. Niven, F.D. Lott, A.Y. Ip, and J.M. Cribbs Pulmonary delivery of powders and solutions containing recombinant human granulocyte colony-stimulating factor (rhG-CSF) to the rabbit Pharm. Res. 11 1994 1101 1109 (Pubitemid 24259848)
29. V.A. Philip, R.C. Mehta, M.K. Mazumder, and P.P. DeLuca Effect of surface treatment on the respirable fractions of PLGA microspheres formulated for dry powder inhalers Int. J. Pharm. 151 1997 165 174 (Pubitemid 27223364)
30. F. Podczeck The influence of particle size distribution and surface roughness of carrier particles on the in vitro properties of dry powder inhalations Aerosol Sci. Technol. 31 1999 301 321 (Pubitemid 32001438)
31. L. Shi, C.J. Plumley, and C. Berkland Biodegradable nanoparticle flocculates for dry powder aerosol formulation Langmuir 23 2007 10897 10901 (Pubitemid 350069300)
32. M. Singh, and V. Waluch Physics and instrumentation for imaging in-vivo drug distribution Adv. Drug Deliv. Rev. 41 2000 7 20 (Pubitemid 30122946)
33. T. Srichana, G.P. Martin, and C. Marriott On the relationship between drug and carrier deposition from dry powder inhalers in vitro Int. J. Pharm. 167 1998 13 23 (Pubitemid 28341504)
34. H. Steckel, and B.W. Müller In vitro evaluation of dry powder inhalers. II. Influence of carrier particle size and concentration on in vitro deposition Int. J. Pharm. 154 1997 31 37 (Pubitemid 27326817)
35. J. Visser Van der Waals and other cohesive forces affecting powder fluidization Powder Technol. 58 1989 1 10
36. Y. Wang, M.S. Hassan, P. Gunawan, R. Lau, X. Wang, and R. Xu Polyelectrolyte mediated formation of hydroxyapatite microspheres of controlled size and hierarchical structure J. Colloid Interface Sci. 339 2009 69 77
37. P.M. Young, S. Edge, D. Traini, M.D. Jones, R. Price, D. El-Sabawi, C. Urry, and C. Smith The influence of dose on the performance of dry powder inhalation systems Int. J. Pharm. 296 2005 26 33 (Pubitemid 40693369)
38. X.-M. Zeng, G.P. Martin, C. Marriott, and J. Pritchard Lactose as a carrier in dry powder formulations: the influence of surface characteristics on drug delivery J. Pharm. Sci. 90 2001 1424 1434 (Pubitemid 32867990)
39. X.M. Zeng, G.P. Martin, C. Marriott, and J. Pritchard The influence of carrier morphology on drug delivery by dry powder inhalers Int. J. Pharm. 200 2000 93 106 (Pubitemid 30177254)
40. X.M. Zeng, G.P. Martin, S.-K. Tee, A.A. Ghoush, and C. Marriott Effects of particle size and adding sequence of fine lactose on the deposition of salbutamol sulphate from a dry powder formulation Int. J. Pharm. 182 1999 133 144 (Pubitemid 29248842)